1. Home
  2. Events
  3. Executive Dysfunction & Emotional Dysregulation in ADHD

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Executive Dysfunction & Emotional Dysregulation in ADHD

Executive dysfunction and emotional dysregulation are common major contributors to ADHD impairment, yet these features are often overlooked during clinical assessments 1-3. Dr. Childress will discuss how to understand and recognize features of executive dysfunction and emotional dysregulation in individuals with attention-deficit/hyperactivity disorder (ADHD). She will review the approaches for assessing executive dysfunction and emotional dysregulation and discuss the limitations of current pharmacological therapies for executive dysfunction and emotional dysregulation.

References:

  1. van Stralen J. Atten Defic Hyperact Disord. 2016;8(4):175-187.
  2. Willcutt EG, et al. Biol Psychiatry. 2005;57(11):1336-1346.
  3. Kosheleff AR, et al. J Atten Disord. 2023;27(7):669-697.

Featuring

Ann-Childress

Ann Childress, MD

President of the Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV

Amaka-Onyereri

Amaka Onyereri, PharmD, BCPS

Medical Science Liaison

More
Amaka Onyereri received her bachelor’s degree in general science and Doctor of Pharmacy degree from Oregon State University/Oregon Health Sciences University. Her passion for patient care led her to practice clinically as a community pharmacist where she served patients for close to 20 years in different capacities as a staff pharmacist, pharmacy manager and pharmacy clinical services manager. As a Pharmacy Clinical Services Manager, Amaka spearheaded various clinical and patient care initiatives such as immunizations, medication therapy management, point of care testing, and most recently a long-acting injectables pilot for antipsychotics.

Disclaimers

Ann Childress, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

Amaka Onyereri, PharmD, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

September 2025    US.CORP.X.25.00194

Registration

Log in to register

Related Resources